Skip header and navigation
Did you mean topic:"vacciner"? Also try vacciner.

Narrow By

36 records – page 1 of 2.

Adult Vaccinations : Changing the Immunization Paradigm

https://libcat.nshealth.ca/en/permalink/provcat44121
Jean-Pierre Michel, Stefania Maggi, editors. --Cham: Springer , 2019.
Available Online
View e-Book
Location
Online
After introductory chapters devoted to the safe production and distribution of vaccines, the book addresses the question of adult vaccination in the framework of a life-course approach to vaccination. It presents the proceedings of multidisciplinary expert discussions with an excellent summary of the current state of knowledge on adult vaccination in various diseases, as well as an overview of the professionals involved and the obstacles to achieving greater vaccine uptake, and how these may be…
Available Online
View e-Book
Other Authors
Michel, Jean-Pierre
Maggi, Stefania
Responsibility
Jean-Pierre Michel, Stefania Maggi, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
2019
Physical Description
1 online resource (viii, 127 p.) : 1 illus. in color
Series
Practical Issues in Geriatrics
Series Title
Practical issues in geriatrics
ISBN
9783030051594
9783030051587 (Print ed.)
9783030051600 (Print ed.)
ISSN
2509-6060
Subjects (MeSH)
Adult
Aging - immunology
Immunization
Vaccination
Vaccines
Specialty
Public Health
Abstract
After introductory chapters devoted to the safe production and distribution of vaccines, the book addresses the question of adult vaccination in the framework of a life-course approach to vaccination. It presents the proceedings of multidisciplinary expert discussions with an excellent summary of the current state of knowledge on adult vaccination in various diseases, as well as an overview of the professionals involved and the obstacles to achieving greater vaccine uptake, and how these may be addressed. The book systematically discusses the major vaccine-preventable diseases, as well as regulatory issues in vaccine provision, and presents the results of an expert meeting designed to identify the obstacles to vaccination, and solutions for addressing these barriers. It goes on to extend the discussion beyond the traditional boundaries of human health to encompass the “one health” concept. The book is intended for all those with an interest in vaccination, including physicians (from a wide range of disciplines including geriatrics/gerontology, infectious diseases, pediatrics, internal medicine, and other non-organ specialties), other healthcare professionals, pharmacists, representatives of the pharmaceutical industry and regulatory bodies (EMEA, national authorities), policymakers, the media and the general public.
Contents
Foreword. Adult vaccinations: essential but too often forgotten -- 1. Complexity of vaccine manufacture and supply -- 2. Administration of vaccines: current process, new technologies, adjuvants -- 3. How can the European Medicines Agency support an appropriate strategy of adult vaccination? -- 4. Public health impact of adult vaccine-preventable diseases on performance, disability, mortality and health care costs in Europe -- 5. Outcomes after HPV vaccination -- 6. Impact of nutrition on adult vaccination efficacy -- 7. Profiling vaccines for an immunosenescent and multimorbid population -- 8. Comprehensive geriatric assessment in infectious diseases -- 9. Etiology of respiratory tract infections in adults in Europe: current knowledge and knowledge gaps -- 10. European flu vaccine regulations and their impacts in community-dwelling adults -- 11. Vaccination against pneumococcal disease in the European Union, with particular focus on Germany -- 12. Direct and indirect benefits of a comprehensive approach to vaccinating adults with influenza and pneumococcal vaccines, especially in patients with chronic diseases -- 13. Vaccination of health care professionals and protection of hospitalized adults and nursing home residents -- 14. Ongoing threats for older Europeans: Diphtheria, Pertussis and Tetanus -- 15. Herpes Zoster vaccination: a vaccine to prevent pain -- 16. Gastroenteritis burden in the adult community: prospects for vaccines -- 17. Travel vaccination -- 18. Integrating the veterinarian scientist to the one-health concept -- 19. Stressing the importance of adult immunization: suggestions for how to change the paradigm -- 20. How can we integrate life course vaccination into the new WHO definition of “Healthy Ageing”?.
Format
e-Book
Location
Online
Less detail

Biologics to Treat Substance Use Disorders : Vaccines, Monoclonal Antibodies, and Enzymes

https://libcat.nshealth.ca/en/permalink/provcat39905
Ivan D. Montoya, editor. (1st ed.) --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This book is a scientific compendium documenting the state of the art in the discovery and development of vaccines, monoclonal antibodies, and enzymes for the treatment of Substance Use Disorders (SUDs). The book gives detailed consideration to some of the most cutting edge topics in addiction medicine, including vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies against cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase…
Available Online
View e-Book
Other Authors
Montoya, Ivan D
Responsibility
Ivan D. Montoya, editor
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xvi, 453 p. : 104 illus., 57 illus. in color)
ISBN
9783319231501
9783319231495 (print ed.)
Subjects (MeSH)
Addiction Medicine - methods
Antibodies, Monoclonal
Biological Products
Enzymes - therapeutic use
Substance-Related Disorders - drug therapy
Vaccines
Abstract
This book is a scientific compendium documenting the state of the art in the discovery and development of vaccines, monoclonal antibodies, and enzymes for the treatment of Substance Use Disorders (SUDs). The book gives detailed consideration to some of the most cutting edge topics in addiction medicine, including vaccines for nicotine, cocaine, heroin, and methamphetamine dependence; monoclonal antibodies against cocaine, methamphetamine, and phencyclidine; and the enzymes butyrylcholinesterase and cocaine esterase. In addition, the text covers a wide range of new strategies designed to optimize the development and efficacy of biologics. Unlike any other resource, this book reviews how biologics offer exciting new therapeutic opportunities for various psychiatric conditions. Written by experts in the field, Biologics to Treat Substance Use Disorders is as an authoritative reference for psychiatrists, psychologists, and all other medical professionals working with patients suffering from Substance Use Disorders.
Contents
1 Introduction: Biologics to Treat Substance Use Disorders: Vaccines, Monoclonal Antibodies, and Enzymes -- Part I. Vaccines -- 2 Therapeutic Vaccines for Treating Nicotine Addiction -- 3 Vaccines for Treating Cocaine Use Disorders -- 4 Vaccines for Opioid Addiction -- 5 Vaccines for Methamphetamine Use Disorder -- 6 Cocaine and HIV Infection -- Part II. Monoclonal Antibodies -- 7 Monoclonal Antibodies -- 8 Anti-cocaine Monoclonal Antibodies -- 9 Discovery and Development of an Anti-methamphetamine Monoclonal Antibody for Use in Treating Methamphetamine Abuse -- Part III. Enzymes -- 10 Enzyme-Based Cocaine Pharmacotherapies: Current Status and Projections for the Future -- 11 Viral Gene Transfer of Enzymes -- 12 Cocaine Hydrolases Designed from Butyrylcholinesterase -- Part IV. Strategies to Optimize the Development of Biologics to Treat Addictions -- 13 Adenovirus-Based Vaccines for the Treatment of Substance Use Disorders -- 14 Nanoparticle-Based Nicotine Vaccine -- 15 Exploration of DNA Nanostructures for Rational Design of Vaccines -- 16 Adjuvants for Substance Abuse Vaccines -- 17 Skin Vaccination Against Nicotine Addiction -- 18 Hapten Design for Anti-addiction Vaccine Development -- 19 B Cell Mechanisms Underlying Vaccine Efficacy Against Drugs of Abuse -- Part V. Practical Considerations -- 20 Practical Considerations for the Development of Vaccines Against Drugs of Abuse -- 21 Ethical Considerations of Biologics to Treat Substance Use Disorders.
Format
e-Book
Location
Online
Less detail

The Clinician's Vaccine Safety Resource Guide : Optimizing Prevention of Vaccine-Preventable Diseases Across the Lifespan

https://libcat.nshealth.ca/en/permalink/provcat42718
Matthew Z. Dudley, Daniel A. Salmon, Neal A. Halsey, Walter A. Orenstein, Rupali J. Limaye, Sean T. O'Leary, Saad B. Omer. --Cham: Springer , c2018.
Available Online
View e-Book
Location
Online
This book provides clinicians and their staff with essential information on the vaccines that are recommended and not recommended for their patients, the diseases these vaccines prevent, and a broad range of potential vaccine safety issues that may be brought up by their patients. Each topic, from specific vaccines to safety concerns, is covered succinctly, based upon systematic reviews of the scientific literature, with talking points to be used with patients. The organization of the informati…
Available Online
View e-Book
Author
Dudley, Matthew Z.
Other Authors
Salmon, Daniel A.
Halsey, Neal A.
Orenstein, Walter A.
Limaye, Rupali J.
O'Leary, Sean T.
Omer, Saad B.
Responsibility
Matthew Z. Dudley, Daniel A. Salmon, Neal A. Halsey, Walter A. Orenstein, Rupali J. Limaye, Sean T. O'Leary, Saad B. Omer
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (xxvi, 392 p.) : 13 illus. in color
ISBN
9783319946948
9783319946931 (print ed.)
9783319946955 (print ed.)
Subjects (MeSH)
Vaccination
Vaccines - adverse effects
Vaccines - therapeutic use
Specialty
Vaccinology
Abstract
This book provides clinicians and their staff with essential information on the vaccines that are recommended and not recommended for their patients, the diseases these vaccines prevent, and a broad range of potential vaccine safety issues that may be brought up by their patients. Each topic, from specific vaccines to safety concerns, is covered succinctly, based upon systematic reviews of the scientific literature, with talking points to be used with patients. The organization of the information makes it easy to reference specific topics and quickly find pertinent information, with the most practical details (such as recommendations and causality conclusions) highlighted at the very beginning of the respective sections. There are also sections outlining the vaccine safety system and evidence-based strategies for how to talk with patients about vaccines. This book aims to improve the efficiency and effectiveness of clinical vaccine discussions with patients, leading to more informed patients and timely vaccination. This is an ideal resource for all clinicians administering vaccines and their healthcare teams.
Contents
Part I: Introduction -- Introduction -- How to Talk with Patients About Vaccines -- Monitoring Vaccine Safety -- Vaccines and Pregnancy -- Vaccines and Breastfeeding -- Part II: Vaccine and Vaccine-Preventable Disease Information Summaries -- Vaccine and Vaccine-Preventable Disease Information Summaries -- Haemophilus influenzae type b (Hib) -- Hepatitis A -- Hepatitis B -- Human Papillomavirus (HPV) -- Influenza -- Measles, Mumps and Rubella -- Meningococcal -- Pneumococcal -- Polio -- Rotavirus -- Tetanus, Diphtheria and Pertussis -- Varicella and Herpes Zoster -- Part III: Potential Adverse Events Following Immunization -- Potential Adverse Events Following Immunization: Summaries of the Evidence -- Do Combination Vaccines or Simultaneous Vaccination Increase the Risk of Adverse Events? -- Do Vaccine Ingredients Cause Adverse Events? -- Do Vaccines Cause Acute Disseminated Encephalomyelitis (ADEM)? -- Do Vaccines Cause Arthralgia or Arthritis? -- Do Vaccines Cause Asthma? -- Do Vaccines Cause Ataxia? -- Do Vaccines Cause Autism? -- Do Vaccines Cause Bell's Palsy? -- Do Vaccines Cause Brachial Neuritis? -- Do Vaccines Cause Chronic Inflammatory Disseminated Polyneuropathy? -- Do Vaccines Cause Complex Regional Pain Syndrome? -- Do Vaccines Cause Deltoid Bursitis? -- Do Vaccines Cause Diabetes? -- Do Vaccines Cause Disseminated Varicella Infection? -- Do Vaccines Cause Erythema Nodosum? -- Do Vaccines Cause Fibromyalgia or Chronic Fatigue Syndrome? -- Do Vaccines Cause Guillain-Barré Syndrome? -- Do Vaccines Cause Hearing Loss? -- Do Vaccines Cause Hepatitis? -- Do Vaccines Cause Herpes Zoster? -- Do Vaccines Cause Hypersensitivity Reactions (e.g. anaphylaxis, hives)? -- Do Vaccines Cause Immune Thrombocytopenic Purpura? -- Do Vaccines Cause Meningitis or Encephalitis/Encephalopathy? -- Do Vaccines Cause Multiple Sclerosis? -- Do Vaccines Cause Myocardial Infarction or Stroke? -- Do Vaccines Cause Myocarditis or Myocardopathy/Cardiomyopathy? -- Do Vaccines Cause Narcolepsy? -- Do Vaccines Cause Oculorespiratory Syndrome? -- Do Vaccines Cause Opsoclonus Myoclonus Syndrome? -- Do Vaccines Cause Optic Neuritis or Neuromyelitis Optica? -- Do Vaccines Cause Primary Ovarian Insufficiency? -- Do Vaccines Cause Seizures? -- Do Vaccines Cause Serum Sickness? -- Do Vaccines Cause Small Fiber Neuropathy? -- Do Vaccines Cause Spontaneous Abortion? -- Do Vaccines Cause Sudden Infant Death Syndrome (SIDS)? -- Do Vaccines Cause Syncope? -- Do Vaccines Cause Systemic Lupus Erythematosus? -- Do Vaccines Cause Transverse Myelitis? -- Do Vaccines Cause Vasculitis or Polyarteritis Nodosa?
Format
e-Book
Location
Online
Less detail

COVID-19 vaccination and cancer FAQ

https://libcat.nshealth.ca/en/permalink/chpams37451
Nova Scotia Health Authority. Cancer Care Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
4000
Available Online
View Pamphlet
As a person living with cancer, or a blood or bone marrow condition, you may have questions about COVID-19 vaccination. This pamphlet explains if the vaccine is safe for people with cancer, how well the vaccine works in people with cancer, when you should get the vaccine, and which vaccine you should get. Possible side effects are listed. Information on who to talk to if you still have questions about the vaccine, and what will happen after you get the vaccine is provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cancer Care Program
Alternate Title
Coronavirus vaccination and cancer FAQ
COVID-19 vaccination and cancer frequently asked questions
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
COVID-19 Vaccines
Neoplasms - complications
Subjects (LCSH)
COVID-19 (Disease)--Vaccination
Cancer--Complications
Abstract
As a person living with cancer, or a blood or bone marrow condition, you may have questions about COVID-19 vaccination. This pamphlet explains if the vaccine is safe for people with cancer, how well the vaccine works in people with cancer, when you should get the vaccine, and which vaccine you should get. Possible side effects are listed. Information on who to talk to if you still have questions about the vaccine, and what will happen after you get the vaccine is provided.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program
Pamphlet Number
4000
Less detail

COVID-19 vaccine and cancer : third doses

https://libcat.nshealth.ca/en/permalink/chpams37496
Nova Scotia Health Authority. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2021.
Pamphlet Number
4009
Available Online
View Pamphlet
As a person living with cancer, you may have questions about whether you will need a third dose of the COVID-19 vaccine. All vaccinations should only be considered after careful assessment of the risks and benefits. This pamphlet explains whether you will need a third dose of COVID-19 vaccine if you have had 2 doses of COVID-19 vaccine. Talk to your cancer care team if you have questions about the vaccine, boosters, and your unique situation.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
COVID-19 Vaccines
Neoplasms
Subjects (LCSH)
COVID-19 (Disease)
Vaccines
Cancer
Specialty
Cancer Care
Abstract
As a person living with cancer, you may have questions about whether you will need a third dose of the COVID-19 vaccine. All vaccinations should only be considered after careful assessment of the risks and benefits. This pamphlet explains whether you will need a third dose of COVID-19 vaccine if you have had 2 doses of COVID-19 vaccine. Talk to your cancer care team if you have questions about the vaccine, boosters, and your unique situation.
Responsibility
Prepared by: Nova Scotia Health Cancer Care Program; Approved by: Nova Scotia Health Cancer Patient Education Committee
Pamphlet Number
4009
Less detail

Drug resistance in leishmania parasites : consequences, molecular mechanisms and possible treatments

https://libcat.nshealth.ca/en/permalink/provcat32519
Alicia Ponte-Sucre, Emilia Diaz, Maritza Padrón-Nieves, editors. --Vienna: Springer , c2013.
Available Online
View e-Book
Location
Online
One of the main problems concerning therapeutic tools for the treatment of parasitic diseases, including leishmaniasis, is that some field parasites are naturally resistant to the classical drugs; additionally, current therapies may select parasites prone to be resistant to the applied drugs. These features are (at least partially) responsible for the disappointing persistence of the disease and resultant deaths worldwide. This book provides a comprehensive view of the pathology of the disease…
Available Online
View e-Book
Other Authors
Ponte-Sucre, Alicia
Diaz, Emilia
Padrón-Nieves, Maritza
Responsibility
Alicia Ponte-Sucre, Emilia Diaz, Maritza Padrón-Nieves, editors
Place of Publication
Vienna
Publisher
Springer
Date of Publication
c2013
Physical Description
1 online resource (xiv, 459 p. : 44 ill., 24 ill. in color)
ISBN
9783709111253
Subjects (MeSH)
Drug Resistance
Leishmania - drug effects
Leishmaniasis
Subjects (LCSH)
Vaccines
Drug interactions
Parasitology
Pharmaceutical technology
Infectious diseases
Microbiology
Abstract
One of the main problems concerning therapeutic tools for the treatment of parasitic diseases, including leishmaniasis, is that some field parasites are naturally resistant to the classical drugs; additionally, current therapies may select parasites prone to be resistant to the applied drugs. These features are (at least partially) responsible for the disappointing persistence of the disease and resultant deaths worldwide. This book provides a comprehensive view of the pathology of the disease itself, and of parasitic drug resistance, its molecular basis, consequences and possible treatments. Scientists both from academic fields and from the industry involved in biomedical research and drug design, will find in this book a valuable and fundamental guide that conveys the knowledge needed to understand and to improve the success in combating this disease worldwide.
Contents
Foreword -- Introduction. Leishmaniasis, the biology of a parasite. Alicia Ponte Sucre -- I Determinant features in leishmaniasis -- 1 Molecular evolution and phylogeny of Leishmania. Gabriele Schoenian, Elisa Cupolillo, Isabel Mauricio -- 2 The role of reservoirs: Canine leishmaniasis. Lenea Campino, Carla Maia -- 3 Epidemiology of leishmaniasis in the time of drug resistance. Jean Claude Dujardin, Saskya Decuypere -- II Leishmania and the immune system -- 4 The role of the immune system in resistance to infection. Lukasz Kedzierski, Krystal J. Evans -- 5 Vaccination as a control measure. Katrin Forber , Heidrun Moll -- 6 Leishmania vaccines: Past, Present and Future. Bhavana Sethu Lakshmi, Rentala Madhubala.- III Challenges in the diagnosis, treatment and control of leishmaniasis in times of drug resistance -- 7 Co-infection with HIV. Margriet den Boer, Luis Rivas, Jorge Alvar.- 8 Visceral leishmaniasis. Shyam Sundar , J aya Chakravarty -- 9 American Tegumentary leishmaniasis. Olga Zerpa, Alicia Ponte-Sucre -- IV Molecular features of drug-resistant Leishmania -- 10 Genetic expression and drug resistance, the role of proteomics. Patricia Cuervo, Jose Batista de Jesus.- 11 The role of ABC transporters in drug-resistant Leishmania. Adriano C Coelho, Paulo C Cotrim -- 12 Functional analysis of Leishmania membrane (non ABC) transporters involved in drug resistance. Scott M Landfear -- 13 Intracellular mechanisms of resistance in Leishmania -- V Pharmacology and chemotherapy of leishmaniasis. Mitali Chatterjee -- 14 Classical vs new Treatment regimens. Louis Maes, Raquel Andreia Inocencio da Luz, Paul Cos, Vanessa Yardley -- 15 Drug targets, drug effectors and drug targeting and delivery. Philippe M Loiseau, Gillian Barratt -- 16 Mechanisms of miltefosine resistance in Leishmania. Francisco Gamarro, Maria P Sanchez-Cacete, Santiago Castanys -- 17 P-glycoprotein-like transporters in Leishmania: a search for reversal agents. Bruno Pradines.- VI Strategies to circumvent drug resistance in Leishmania -- 18 The relevance of susceptibility tests, breakpoints and markers. Louis Maes, Paul Cos and Simon Croft -- 19 The Concept of Fitness and drug resistance in Leishmania. Alicia Ponte-Sucre, Emilia Diaz, Maritza Padron-Nieves.
Format
e-Book
Location
Online
Less detail

Encyclopedia of Medical Immunology

https://libcat.nshealth.ca/en/permalink/provcat44527
editors, Ian MacKay, Noel R. Rose. --New York, NY: Springer , c2019.
Available Online
View e-Book
Location
Online
Offering a broad appeal to microbiologists, immunologists, and infectious disease specialists, this four volume encyclopedia covers all autoimmune, tropical, and infectious diseases. Emphasis will also be placed on genetics, physiology, metabolism, pathogenesis and applied microbiology. Under the leadership of some of the most world renowned names in the field, the encyclopedia will bring together an outstanding collection of contributions by top scientists in a variety of fields. Volumes 1-3: …
Available Online
View e-Book
Other Authors
MacKay, Ian
Rose, Noel R.
Responsibility
editors, Ian MacKay, Noel R. Rose
Place of Publication
New York, NY
Publisher
Springer
Date of Publication
c2019
Physical Description
1 online resource (approx. 1000 p.)
Series Title
Springer reference
ISBN
9781461492092
Subjects (MeSH)
Autoimmune Diseases
Communicable Diseases - immunology
Immune System Phenomena
Immunology
Vaccination
Vaccines
Specialty
Allergy and Immunology
Notes
"Living edition."
Abstract
Offering a broad appeal to microbiologists, immunologists, and infectious disease specialists, this four volume encyclopedia covers all autoimmune, tropical, and infectious diseases. Emphasis will also be placed on genetics, physiology, metabolism, pathogenesis and applied microbiology. Under the leadership of some of the most world renowned names in the field, the encyclopedia will bring together an outstanding collection of contributions by top scientists in a variety of fields. Volumes 1-3: Diseases will be divided by the 11 main sections of the body, namely Integumentary, Skeletal, Respiratory, Digestive, Urinary, and Reproductive. For some of the autoimmune disease, more then one system will be involved but the delineation serves to broadly break down the diseases into systems. Volume 4 will cover the vaccines for said diseases and future prospects will be offered by leaders in industry and academia. Volume 4 will also be broken down into all the body systems, as in the other two volumes. For each vaccine, for each disease, and in each system the following will be included: A list of the vaccines currently available along with a list of the companies that manufacture them; Molecular immunology of the vaccine; Type of immunity involved in protection; Mode of vaccination for each vaccine; Repeated boosters and length of immunological memory; Commercial production of vaccines; Storage of vaccines; Standardization and control of vaccines; WHO programs and world-wide disease eradication programs based upon vaccines.
Format
e-Book
Publication Type
Encyclopedia
Location
Online
Less detail

The 'Flu Shot' : Information for Cancer Patients, Survivors and Family Members

https://libcat.nshealth.ca/en/permalink/chpams37359
Nova Scotia Health. Cancer Care Program. [Halifax, NS]: Nova Scotia Health Cancer Care Program , 2020.
Pamphlet Number
0031
Available Online
View Pamphlet
Patients currently on treatment for cancer should have the flu shot with a standard dose, inactive (not live) vaccine. This pamphlet lists the reasons for getting a flu shot, what it does not prevent, who should get it and when based on cancer treatments. It also lists the symptoms and steps if you have symptoms of the flu or COVID-19.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Cancer Care Program
Place of Publication
[Halifax, NS]
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Influenza Vaccines
Neoplasms - therapy
Subjects (LCSH)
Cancer--Patients
Influenza vaccines
Specialty
Pharmacy
Self Care
Abstract
Patients currently on treatment for cancer should have the flu shot with a standard dose, inactive (not live) vaccine. This pamphlet lists the reasons for getting a flu shot, what it does not prevent, who should get it and when based on cancer treatments. It also lists the symptoms and steps if you have symptoms of the flu or COVID-19.
Notes
Patient & family guide
Responsibility
prepared by Nova Scotia Health Cancer Care Program
Pamphlet Number
0031
Less detail

Gram-positive pathogens

https://libcat.nshealth.ca/en/permalink/provcat22857
Fischetti, Vincent A. (2nd ed.) --Washington, DC: ASM Press , 2006.
Call Number
QW 142 G745 2006
Location
Dickson Building
Call Number
QW 142 G745 2006
Author
Fischetti, Vincent A
Edition
2nd ed.
Place of Publication
Washington, DC
Publisher
ASM Press
Date of Publication
2006
Physical Description
849 p.
ISBN
1555813437
9781555813437
Subjects (MeSH)
Gram-Positive Bacteria
Gram-Positive Bacterial Infections
Bacterial Vaccines
Drug Resistance, Microbial
Format
Book
Location
Dickson Building
Loan Period
3 weeks
Less detail

The Grand Challenge for the Future : Vaccines for Poverty-Related Diseases from Bench to Field

https://libcat.nshealth.ca/en/permalink/provcat29224
edited by Stefan H.E. Kaufmann, Paul-Henri Lambert. --Basel: Birkhäuser Verlag , c2005.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Kaufmann, Stefan H.E
Other Authors
Lambert, Paul-Henri
Responsibility
edited by Stefan H.E. Kaufmann, Paul-Henri Lambert
Place of Publication
Basel
Publisher
Birkhäuser Verlag
Date of Publication
c2005
Series Title
Birkhäuser advances in infectious diseases
ISBN
9783764373818
Subjects (MeSH)
Vaccination - trends
Vaccines
Developing Countries
Poverty Areas
Clinical Trials as Topic
Drug Design
Subjects (LCSH)
Public health
Infectious diseases
Format
e-Book
Location
Online
Less detail

Handbook of Hepatitis C

https://libcat.nshealth.ca/en/permalink/provcat40074
Nicolas Goossens, Sophie Clément, Francesco Negro, editors. --Cham: Springer International Publishing : Imprint: Adis , c2016.
Available Online
View e-Book
Location
Online
This book is a concise and up-to-date review of the clinical features, pathophysiology, diagnosis, and treatment of patients with hepatitis C. Busy health care professionals who want a quick review of hepatitis C and new developments in treatment for hepatitis C will benefit from this succinct guide. Hepatitis C virus primarily infects liver cells and can lead to chronic damage to the liver. Patients with hepatitis C infection often develop liver sequelae such as fibrosis, cirrhosis, and hepato…
Available Online
View e-Book
Other Authors
Goossens, Nicolas
Clément, Sophie
Negro, Francesco
Responsibility
Nicolas Goossens, Sophie Clément, Francesco Negro, editors
Place of Publication
Cham
Publisher
Springer International Publishing : Imprint: Adis
Date of Publication
c2016
Physical Description
1 online resource (xi, 82 p. : 19 illus. in color)
ISBN
9783319280530
9783319280516 (print ed.)
Subjects (MeSH)
Hepacivirus
Hepatitis C
Viral Hepatitis Vaccines - therapeutic use
Specialty
Gastroenterology
Virology
Abstract
This book is a concise and up-to-date review of the clinical features, pathophysiology, diagnosis, and treatment of patients with hepatitis C. Busy health care professionals who want a quick review of hepatitis C and new developments in treatment for hepatitis C will benefit from this succinct guide. Hepatitis C virus primarily infects liver cells and can lead to chronic damage to the liver. Patients with hepatitis C infection often develop liver sequelae such as fibrosis, cirrhosis, and hepatocellular carcinoma if left untreated. It is estimated that 150 million people worldwide are infected with hepatitis C virus, and if eradication is to be achieved it is imperative to diagnose and treat such individuals.
Contents
Introduction -- The HCV particle and its lifecycle -- Clinical features -- Pathophysiology -- Diagnosis -- Management of HCV infection -- Future challenges.
Format
e-Book
Publication Type
Handbook
Location
Online
Less detail

The health professional's HPV handbook. 1, Human papillomavirus and cervical cancer

https://libcat.nshealth.ca/en/permalink/provcat38610
editors-in-chief, Walter Prendiville, Philip Davies. --London: Taylor & Francis , 2004.
Call Number
WP 480 H434 2004
Location
Dickson Building
Call Number
WP 480 H434 2004
Other Authors
Prendiville, Walter
Davies, Philip
Other Authors
European Consortium for Cervical Cancer Education
Responsibility
editors-in-chief, Walter Prendiville, Philip Davies
Alternate Title
HPV handbook
Human papillomavirus and cervical cancer
Place of Publication
London
Publisher
Taylor & Francis
Date of Publication
2004
Physical Description
94 p.
ISBN
9781842143360
1842143360
Subjects (MeSH)
Uterine Cervical Neoplasms
Papillomaviridae
Papillomavirus Vaccines
Alphapapillomavirus
Gammapapillomavirus
Sexually Transmitted Diseases, Viral
Subjects (LCSH)
Cervix uteri--Cancer--Handbooks, manuals, etc
Papillomaviruses--Handbooks, manuals, etc
Notes
"ECCCE, European Consortium for Cervical Cancer Education"--Cover
Format
Book
Publication Type
Handbook
Location
Dickson Building
Loan Period
3 weeks
Less detail

HPV Infection in Head and Neck Cancer

https://libcat.nshealth.ca/en/permalink/provcat41484
Wojciech Golusinski, C. René Leemans, Andreas Dietz. --Cham: Springer , 2017.
Available Online
View e-Book
Location
Online
This book is exceptional in presenting an interdisciplinary approach to the subject of human papillomavirus (HPV) infection in the context of head and neck cancer. Leading experts in the field discuss the epidemiology and molecular biology of HPV-positive head and neck squamous cell carcinoma, HPV testing, the nonsurgical and surgical treatment of HPV-positive tumors, predictive factors for outcome and quality of life, and ongoing trials on the effectiveness of vaccination in disease prevention…
Available Online
View e-Book
Other Authors
Golusinski, Wojciech
Leemans, C. René
Dietz, Andreas
Responsibility
Wojciech Golusinski, C. René Leemans, Andreas Dietz
Place of Publication
Cham
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (vi, 267 pages) : 42 illus., 29 illus. in color
Series Vol.
206
Series Title
Recent results in cancer research
ISBN
9783319435800
9783319435787 (print ed.)
ISSN
0080-0015
Subjects (MeSH)
Carcinoma, Squamous Cell
Head and Neck Neoplasms
Papillomaviridae - pathogenicity
Papillomavirus Infections
Papillomavirus Vaccines - therapeutic use
Abstract
This book is exceptional in presenting an interdisciplinary approach to the subject of human papillomavirus (HPV) infection in the context of head and neck cancer. Leading experts in the field discuss the epidemiology and molecular biology of HPV-positive head and neck squamous cell carcinoma, HPV testing, the nonsurgical and surgical treatment of HPV-positive tumors, predictive factors for outcome and quality of life, and ongoing trials on the effectiveness of vaccination in disease prevention. It also provides recommendations for testing, diagnosis treatment and vaccination. Otolaryngologists, head and neck surgeons, medical oncologists, radiation oncologists, molecular biologists and pathologists will find this book a valuable resource.
Contents
Part I. Epidemiology and molecular biology of HPV positive HNSCC -- Part II. HPV testing -- Part III. Non-surgical treatment of HPV positive tumours -- Part IV. Surgical treatment of HPV positive tumours -- Part V. Predictive factors for outcome and quality of life in HPV positive and HPV negative -- Part VI. HPV : prevention vaccination, ongoing trials.
Format
e-Book
Location
Online
Less detail

Immunotherapy of Cancer : An Innovative Treatment Comes of Age

https://libcat.nshealth.ca/en/permalink/provcat40389
Yoshiyuki Yamaguchi, editor. (1st ed.) --Tokyo: Springer Japan , c2016.
Available Online
View e-Book
Location
Online
This timely book, published just as cancer immunotherapy comes of age, summarizes the rationale, present status, and future perspective for cancer immunotherapy. Included are explanations of the constitution of the immune system and immunocheckpoints, the mechanism of antigen presentation and recognition, valuable modalities, clinical trials and guidance, personalization, and biomarkers, all of which are essential for understanding the success of cancer immunotherapy. This innovative therapy ha…
Available Online
View e-Book
Other Authors
Yamaguchi, Yoshiyuki
Responsibility
Yoshiyuki Yamaguchi, editor
Edition
1st ed.
Place of Publication
Tokyo
Publisher
Springer Japan
Date of Publication
c2016
Physical Description
1 online resource (ix, 358 p. : 46 illus., 8 illus. in color)
ISBN
9784431550310
9784431550303 (print ed.)
Subjects (MeSH)
Adjuvants, Immunologic - therapeutic use
Cancer Vaccines
Immunotherapy
Neoplasms - immunology
Neoplasms - therapy
Abstract
This timely book, published just as cancer immunotherapy comes of age, summarizes the rationale, present status, and future perspective for cancer immunotherapy. Included are explanations of the constitution of the immune system and immunocheckpoints, the mechanism of antigen presentation and recognition, valuable modalities, clinical trials and guidance, personalization, and biomarkers, all of which are essential for understanding the success of cancer immunotherapy. This innovative therapy has been investigated worldwide as the fourth line of cancer treatment after the standard treatments of surgery, chemotherapy, and radiotherapy. The progress in fundamental understanding of tumor immunology and the recent advances in clinical trials have opened new avenues with a cancer vaccine in 2010 and immunocheckpoint modulation in 2011, with their approval already granted in the United States. Today, there are no doubts, even among experts in cancer chemotherapy and radiotherapy, that the immune system plays a vital role in tumor eradication. Following American approval, many clinical trials of cancer immunotherapy are being conducted. With this book the reader will readily understand the paradigm shift in cancer treatment and will realize the importance of cancer immunotherapy. The great value of immunotherapy will be obvious, not only for tumor shrinkage but for prolonging patient survival.
Contents
Part I. Overview, History, Classification -- 1. Overview of Current Cancer Immunotherapy -- Part II. BRMs and Crude Agents -- 2. Bacterial Preparations -- 3. Polysaccharides -- 4. BCG -- Part III. Cytokines -- 5. ø-T Cells -- 6. NKT Cell-Based Immunotherapy -- 7. Natural Killer Cells -- 8. þ T Cell-Based Cancer Immunotherapy -- 9. Genetically engineered T cells -- Part IV. Vaccine Therapy -- 10. Peptide Vaccine -- 11. Personalized Peptide Vaccine -- 12. WT1 Peptide Vaccine for the Treatment of Malignancies -- 13. Protein vaccine -- 14. Dendritic Cell-Based Vaccine for Cancer -- Part V. Immunoadjuvants -- 15. CpG Motif -- 16. Pattern Recognition by Dendritic Cells and Its Application to Vaccine Adjuvant for Antitumor Immunotherapy -- 17. Novel Adjuvants -- Part VI. Immunocheckpoints -- 18. Anti-CTLA-4 Ab -- 19. Anti-PD-1, PD-L1 Ab -- 20. Novel Targets of Immune Inhibitory and Stimulatory Co-signals -- Part VII. Regulation of Immunosuppression -- 21. Regulatory T Cells -- 22. MDSC: Myeloid-Derived Suppressor Cells -- Part VIII. Immune-Related Response Criteria and Guidance for Clinical Trials -- 23. Immune-Related Response Criteria and Guidance for Clinical Trials -- Part IX. Personalized Immunotherapy -- 24. Personalized cancer immunotherapy: Immune biomarkers and combination immunotherapy.
Format
e-Book
Location
Online
Less detail

Infectious Diseases : Selected Entries from the Encyclopedia of Sustainability Science and Technology

https://libcat.nshealth.ca/en/permalink/provcat32434
Phyllis Kanki, Darrell Jay Grimes, editors. --New York, NY: Springer , c2013.
Available Online
View e-Book
Location
Online
Infectious Diseases: Selected Entries from the Encyclopedia of Sustainability Science and Technology presents authoritative, peer-reviewed contributions from leading experts on a wide range of major infectious diseases of global importance. Infectious diseases account for more than 17 million deaths each year worldwide. While modern medicine and technology have diminished the threat of many of these pathogens in high-income countries, the ever present threats of re-emerging infections, populati…
Available Online
View e-Book
Other Authors
Kanki, Phyllis
Grimes, Darrell Jay
Responsibility
Phyllis Kanki, Darrell Jay Grimes, editors
Place of Publication
New York, NY
Publisher
Springer
Date of Publication
c2013
Physical Description
1 online resource (vi, 505 p. : 75 ill., 61 ill. in color)
ISBN
9781461457190
Subjects (MeSH)
Communicable Diseases
Global Health
Subjects (LCSH)
Vaccines
Public health
Infectious diseases
Epidemiology
Marine Sciences
Abstract
Infectious Diseases: Selected Entries from the Encyclopedia of Sustainability Science and Technology presents authoritative, peer-reviewed contributions from leading experts on a wide range of major infectious diseases of global importance. Infectious diseases account for more than 17 million deaths each year worldwide. While modern medicine and technology have diminished the threat of many of these pathogens in high-income countries, the ever present threats of re-emerging infections, population mobility, natural disasters, and pathogen genetic variability are but some of the reasons for the dynamic threat of this broad category of risks to human health. An indispensable resource for students and scientists, the volume also covers some of the new technologies currently under development for infectious disease prevention, treatment, and eradication. The greater part of the infectious disease burden remains in the tropics, where low and middle-income countries lack the resources, infrastructure, and health systems to mount or sustain control efforts. Many contributions describe the efforts of the scientific research community and international donor agencies to achieve the integrated goals of vigilant surveillance, improved and cost-effective diagnostics, and treatment for sustainable disease control. Describes the dynamic nature of infectious disease agents and their complex interactions with the environment and their human and animal hosts; Covers new technologies for antibiotics, vaccines, and treatment; Features several contributions on waterborne infectious diseases, including enteric viruses and bacterial pathogens in the ocean; Provides an excellent introduction for those entering the field, as well as new insights for advanced researchers and industry experts.
Contents
1. Infectious Diseases, Introduction -- 2. Antibiotics for Emerging Pathogens -- 3. HIV/AIDS Global Epidemic -- 4. Human Bacterial Diseases from Ocean -- 5. Infectious Disease Modeling -- 6. Infectious Diseases, Climate Change Effects on -- 7. Infectious Diseases, Vibrational Spectroscopic Approaches to Rapid Diagnostics -- 8. Malaria Vaccines -- 9. Marine and Freshwater Fecal Indicators and Source Identification -- 10. Polio and Its Epidemiology -- 11. Tropical Health and Sustainability -- 12. Tuberculosis, Epidemiology of -- 13. Waterborne Diseases of the Ocean, Enteric Viruses -- 14. Waterborne Infectious Diseases, Approaches to Control -- 15. Waterborne Parasitic Diseases in Ocean -- Index.
Format
e-Book
Location
Online
Less detail

In the blink of an eye : the deadly story of epidemic meningitis

https://libcat.nshealth.ca/en/permalink/provcat32404
Andrew W. Artenstein, author. --New York, NY: Springer , c2013.
Available Online
View e-Book
Location
Online
Describing more than two centuries of epidemic meningitis, In the Blink of an Eye introduces a deadly and frightening bacterial infection of the brain, one that afflicts healthy children and young adults in dramatic fashion, often changing or taking lives in just hours or days. Meningococcal meningitis is the culprit, causing sporadic cases as well as explosive, unpredictable outbreaks of disease throughout the world, leading to the deaths of dozens to hundreds of thousands every year. Beginnin…
Available Online
View e-Book
Author
Artenstein, Andrew W
Responsibility
Andrew W. Artenstein, author
Place of Publication
New York, NY
Publisher
Springer
Date of Publication
c2013
Physical Description
1 online resource (ix, 138 p. : 22 ill., 5 ill. in color)
ISBN
9781461448457
Subjects (MeSH)
Meningitis, Meningococcal - history
Vaccines - history
Subjects (LCSH)
Infectious diseases
Abstract
Describing more than two centuries of epidemic meningitis, In the Blink of an Eye introduces a deadly and frightening bacterial infection of the brain, one that afflicts healthy children and young adults in dramatic fashion, often changing or taking lives in just hours or days. Meningococcal meningitis is the culprit, causing sporadic cases as well as explosive, unpredictable outbreaks of disease throughout the world, leading to the deaths of dozens to hundreds of thousands every year. Beginning with the case of a healthy teenage boy who rapidly succumbs to the disease, the book traces meningitis through its various social contexts. From the acceptance of the germ theory of disease and the birth of the sister sciences of microbiology and immunology in the nineteenth century to the modern molecular era, the story traverses more than 200 years of medical history. It leads us through the early descriptions of the disease, its impact on military forces, large outbreaks of meningitis in Africa and elsewhere, and the evolution of approaches to its treatment, control, and prevention. In so doing, we witness the development of modern medical research and education, the discovery of antibiotics, the rapid emergence of drug-resistant bacteria, the invention of a novel class of vaccines, and learn the inner workings of disease processes and the human immune system. The story of meningococcal meningitis, winding through the evolution of infectious diseases, the great European capitals of nineteenth century science, the Rockefeller Institute, the dye industry, Nazi Germany, military medicine, the Vietnam era, and prospects for an end to epidemic disease, parallels the rise of modern medical science.
Contents
Origins -- The Art and Science of Germs -- A Singular Disease -- A Very Mortal Disease -- Early Approaches at Therapy -- Antibiotics and Survival of the Fittest -- A Brief History of Vaccines -- That Soulble Specific Substance -- Towards a Vaccine -- Success for Half -- The Future of a Killer.
Format
e-Book
Location
Online
Less detail

Keeping vaccine safe

https://libcat.nshealth.ca/en/permalink/chpams35920
Nova Scotia Health Authority. Public Health. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1869
Available Online
View Pamphlet
This pamphlet outlines the steps taken for keeping vaccine safe. It lists information regarding ordering, storing, handling, and transporting vaccine. It outlines steps that need to be taken for disposing of expired vaccine. Recording of vaccine is also explained. A list of Public Health phone numbers is provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Public Health
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (2 p.) : digital, PDF file
Subjects (MeSH)
Vaccines
Subjects (LCSH)
Vaccines
Abstract
This pamphlet outlines the steps taken for keeping vaccine safe. It lists information regarding ordering, storing, handling, and transporting vaccine. It outlines steps that need to be taken for disposing of expired vaccine. Recording of vaccine is also explained. A list of Public Health phone numbers is provided.
Responsibility
Prepared by: Public Health
Pamphlet Number
1869
Less detail

New generation vaccines

https://libcat.nshealth.ca/en/permalink/provcat24720
Levine, Myron M. (4th ed.) --New York, NY: Informa Healthcare , 2010.
Call Number
QW 805 N532 2010 REF
Location
Dickson Building
Sub-Location
REFERENCE
Call Number
QW 805 N532 2010 REF
Author
Levine, Myron M
Edition
4th ed.
Place of Publication
New York, NY
Publisher
Informa Healthcare
Date of Publication
2010
Physical Description
1011 p.
ISBN
9781420060737
Subjects (MeSH)
Vaccines
Format
Book
Location
Dickson Building
Sub-Location
REFERENCE
Loan Period
In library use
Less detail

Oncoimmunology : A Practical Guide for Cancer Immunotherapy

https://libcat.nshealth.ca/en/permalink/provcat42777
Laurence Zitvogel, Guido Kroemer, editors. --Cham: Springer , c2018.
Available Online
View e-Book
Location
Online
In this book, leading experts in cancer immunotherapy join forces to provide a comprehensive guide that sets out the main principles of oncoimmunology and examines the latest advances and their implications for clinical practice, focusing in particular on drugs with FDA/EMA approvals and breakthrough status. The aim is to deliver a landmark educational tool that will serve as the definitive reference for MD and PhD students while also meeting the needs of established researchers and healthcare …
Available Online
View e-Book
Other Authors
Zitvogel, Laurence
Kroemer, Guido
Responsibility
Laurence Zitvogel, Guido Kroemer, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (x, 724 p.) : 133 illus., 131 illus. in color
ISBN
9783319624310
9783319624303 (print ed.)
9783319624327 (print ed.)
9783319873107 (print ed.)
Subjects (MeSH)
Cancer Vaccines
Immunotherapy
Neoplasms - immunology
Neoplasms - therapy
Specialty
Medical Oncology
Vaccinology
Abstract
In this book, leading experts in cancer immunotherapy join forces to provide a comprehensive guide that sets out the main principles of oncoimmunology and examines the latest advances and their implications for clinical practice, focusing in particular on drugs with FDA/EMA approvals and breakthrough status. The aim is to deliver a landmark educational tool that will serve as the definitive reference for MD and PhD students while also meeting the needs of established researchers and healthcare professionals. Immunotherapy-based approaches are now inducing long-lasting clinical responses across multiple histological types of neoplasia, in previously difficult-to-treat metastatic cancers. The future challenges for oncologists are to understand and exploit the cellular and molecular components of complex immune networks, to optimize combinatorial regimens, to avoid immune-related side effects, and to plan immunomonitoring studies for biomarker discovery. The editors hope that this book will guide future and established health professionals toward the effective application of cancer immunology and immunotherapy and contribute significantly to further progress in the field.
Contents
1. Principles of Oncoimmunology -- Part I. Fundamentals in I-O -- 2. The Human Tumor Microenvironment -- 3. CD8+ T Cells in Immunotherapy, Radiotherapy, and Chemotherapy -- 4. Mutant Epitopes in Cancer -- 5. The Secrets of T Cell Polarization -- 6. Regulatory T Cells: Their Role, Mechanism of Action, and Impact on Cancer -- 7. Purinergic Receptors: Novel Targets for Cancer Immunotherapy -- 8. Plasmacytoid DC/Regulatory T Cell Interactions at the Center of an Immunosuppressive Network in Breast and Ovarian Tumors -- 9. Cancer Immunosurveillance by Natural Killer Cells and Other Innate Lymphoid Cells -- 10. Biology of Myeloid-Derived Suppressor Cells -- 11. Effect of Pharmaceutical Compounds on Myeloid-Derived Suppressor Cells -- 12. Immunogenic Stress and Death of Cancer Cells in Natural and Therapy-Induced Immunosurveillance -- 13. Genetics and Immunology: Tumor-Specific Genetic Alterations as a Target for Immune Modulating Therapies -- Part II. Breakthrough Status -- 14. Peptide-Based Therapeutic Cancer Vaccines -- 15. Cancer Vaccines for HPV Malignancies -- 16. NK Cell-Based Therapies -- 17. IDO/TDO Inhibition in Cancer -- Part III FDA-EMA Approval of I-O -- 18. Tumor-Targeted Antibodies -- 19. PD1 Checkpoint Blockade in Melanoma: From Monotherapy to Combination Therapies -- 20. Immune Checkpoint Inhibition in Lung Cancer -- 21. PD-1 Blockade in Renal Cell Carcinoma -- 22. BCG and Anti-PDL-1 Ab in Bladder Cancers -- 23. PD-L1 and Other Immunological Diagnosis Tools -- 24. Oncolytic Viruses: T-VEC and Others -- Part IV. Developing Fields -- 25. Innate Immune Receptors in the Regulation of Tumor Immunity -- 26. Co-stimulation Agonists via CD137, OX40, GITR, and CD27 for Immunotherapy of Cancer -- 27. The Impact of the Intestinal Microbiota in Therapeutic Responses Against Cancer -- 28. Local Immunotherapies of Cancer -- 29. Strategies to Reduce Intratumoral Regulatory T Cells -- 30. Synergy Between Radiotherapy and Immunotherapy -- 31. Predictors of Response to Immune Checkpoint Blockade -- Part V. Changes in Clinical Practice -- 32. Immune Therapies in Phase 1 Trials -- 33. Side Effects of Cancer Immunotherapy with Checkpoint Inhibitors -- 34. Melanoma: Immunotherapy in Advanced Melanoma and in the Adjuvant Setting -- 35. Immunotherapy for Prostate Cancer: An Evolving Landscape -- 36. Challenges of Oncoimmunology for Ovarian and Breast Cancers -- 37. Challenges in Colorectal Cancer: From Vaccines to Macrophage Repolarization -- 38. Current Status of Immuno-Oncology in Hematologic Cancers -- 39. Immunotherapy of Gliomas -- 40. Assessing T Cell Receptor Affinity and Avidity Against Tumor Antigens -- 41. Immune Monitoring of Blood and Tumor Microenvironment -- 42. Toward Engineered Cells as Transformational and Broadly Available Medicines for the Treatment of Cancer -- Part VI. Concluding Remarks -- 43. Concluding Remarks.
Format
e-Book
Location
Online
Less detail

Plotkin's vaccines

https://libcat.nshealth.ca/en/permalink/provcat32092
edited by Stanley A. Plotkin, Walter A. Orenstein, Paul A. Offit. (7th ed.) --Philadelphia, PA: Elsevier , c2018.
Available Online
View e-Book
Access
Registration required for PDF access.
Location
Online
Available Online
View e-Book
Other Authors
Plotkin, Stanley A
Orenstein, Walter A
Offit, Paul A
Responsibility
edited by Stanley A. Plotkin, Walter A. Orenstein, Paul A. Offit
Edition
7th ed.
Alternate Title
Vaccines
Place of Publication
Philadelphia, PA
Publisher
Elsevier
Date of Publication
c2018
Physical Description
1 online resource
ISBN
9780323357616
Subjects (MeSH)
Immunization Programs
Vaccination
Vaccines
Subjects (LCSH)
Vaccines
Immunization Programs
Specialty
Vaccinology
Access
Registration required for PDF access.
Format
e-Book
Location
Online
Less detail

36 records – page 1 of 2.